AAAAAA
Results: 1-25/28
Authors:
Rhee, HW
Zhau, HE
Pathak, S
Multani, AS
Pennanen, S
Visakorpi, T
Chung, LWK
Citation: Hw. Rhee et al., Permanent phenotypic and genotypic changes of prostate cancer cells cultured in a three-dimensional rotating-wall vessel, IN VITRO-AN, 37(3), 2001, pp. 127-140
Authors:
Pan, Y
Lui, WO
Nupponen, N
Larsson, C
Isola, J
Visakorpi, T
Bergerheim, USR
Kytola, S
Citation: Y. Pan et al., 5q11, 8p11, and 10q22 are recurrent chromosomal breakpoints in prostate cancer cell lines, GENE CHROM, 30(2), 2001, pp. 187-195
Authors:
Loimas, S
Toppinen, MR
Visakorpi, T
Janne, J
Wahlfors, J
Citation: S. Loimas et al., Human prostate carcinoma cells as targets for herpes simplex virus thymidine kinase-mediated suicide gene therapy, CANC GENE T, 8(2), 2001, pp. 137-144
Authors:
Elo, JP
Visakorpi, T
Citation: Jp. Elo et T. Visakorpi, Molecular genetics of prostate cancer, ANN MED, 33(2), 2001, pp. 130-141
Authors:
Schalken, J
Visakorpi, T
Thalmann, G
van der Poel, H
Citation: J. Schalken et al., Molecular biology for urologists, EUR UROL, 39(4), 2001, pp. 1-11
Authors:
Saramaki, OR
Savinainen, KJ
Nupponen, NN
Bratt, O
Visakorpi, T
Citation: Or. Saramaki et al., Amplification of hypoxia-inducible factor 1 alpha gene in prostate cancer, CANC GENET, 128(1), 2001, pp. 31-34
Authors:
Isola, J
Auvinen, A
Poutiainen, M
Kakkola, L
Jarvinen, TAH
Maattanen, L
Stenman, UH
Tammela, T
Hakama, M
Visakorpi, T
Citation: J. Isola et al., Predictors of biological aggressiveness of prostate specific antigen screening detected prostate cancer, J UROL, 165(5), 2001, pp. 1569-1573
Authors:
Porkka, KP
Visakorpi, T
Citation: Kp. Porkka et T. Visakorpi, Detection of differentially expressed genes in prostate cancer by combining suppression subtractive hybridization and cDNA library array, J PATHOLOGY, 193(1), 2001, pp. 73-79
Authors:
Linja, MJ
Savinainen, KJ
Saramaki, OR
Tammela, TLJ
Vessella, RL
Visakorpi, T
Citation: Mj. Linja et al., Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer, CANCER RES, 61(9), 2001, pp. 3550-3555
Authors:
Helenius, MA
Saramaki, OR
Linja, MJ
Tammela, TLJ
Visakorpi, T
Citation: Ma. Helenius et al., Amplification of urokinase gene in prostate cancer, CANCER RES, 61(14), 2001, pp. 5340-5344
Authors:
Saramaki, O
Willi, N
Bratt, O
Gasser, TC
Koivisto, P
Nupponen, NN
Bubendorf, L
Visakorpi, T
Citation: O. Saramaki et al., Amplification of EIF3S3 gene is associated with advanced stage in prostatecancer, AM J PATH, 159(6), 2001, pp. 2089-2094
Authors:
Visakorpi, T
Citation: T. Visakorpi, AR gene alterations in prostate cancer progression, CONT CANC R, 2001, pp. 29-37
Authors:
Hernes, EH
Linja, M
Fossa, SD
Visakorpi, T
Berner, A
Winderen, M
Koivisto, PA
Citation: Eh. Hernes et al., Hormone-resistant prostate cancer with symptomatic pelvic tumours: patientsurvival and prognostic factors, BJU INT, 86(3), 2000, pp. 240-247
Authors:
Nupponen, NN
Visakorpi, T
Citation: Nn. Nupponen et T. Visakorpi, Molecular cytogenetics of prostate cancer, MICROSC RES, 51(5), 2000, pp. 456-463
Authors:
Nupponen, NN
Isola, J
Visakorpi, T
Citation: Nn. Nupponen et al., Mapping the amplification of EIF3S3 in breast and prostate cancer, GENE CHROM, 28(2), 2000, pp. 203-210
Authors:
Koski, T
Karhu, R
Visakorpi, T
Vilpo, L
Knuutila, S
Vilpo, J
Citation: T. Koski et al., Complex chromosomal aberrations in chronic lymphocytic leukemia are associated with cellular drug and irradiation resistance, EUR J HAEMA, 65(1), 2000, pp. 32-39
Authors:
Palmberg, C
Koivisto, P
Kakkola, L
Tammela, TLJ
Kallioniemi, OP
Visakorpi, T
Citation: C. Palmberg et al., Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer, J UROL, 164(6), 2000, pp. 1992-1995
Authors:
Lindfors, K
Halttunen, T
Huotari, P
Nupponen, N
Vihinen, M
Visakorpi, T
Maki, M
Kainulainen, H
Citation: K. Lindfors et al., Identification of novel transcription factor-like gene from human intestinal cells, BIOC BIOP R, 276(2), 2000, pp. 660-666
Authors:
Visakorpi, T
Citation: T. Visakorpi, New pieces to the prostate cancer puzzle, NAT MED, 5(3), 1999, pp. 264-265
Authors:
Visakorpi, T
Citation: T. Visakorpi, Molecular genetics of prostate cancer, ANN CHIR GY, 88(1), 1999, pp. 11-16
Authors:
Haapasalo, H
Sallinen, SL
Sallinen, P
Helen, P
Jaaskelainen, J
Salmi, TT
Paetau, A
Paljarvi, L
Visakorpi, T
Kalimo, H
Citation: H. Haapasalo et al., Clinicopathological correlation of cell proliferation, apoptosis and p53 in cerebellar pilocytic astrocytomas, NEUROP AP N, 25(2), 1999, pp. 134-142
Authors:
Palmberg, C
Koivisto, P
Visakorpi, T
Tammela, TLJ
Citation: C. Palmberg et al., PSA decline is an independent prognostic marker in hormonally treated prostate cancer, EUR UROL, 36(3), 1999, pp. 191-196
Authors:
Nupponen, N
Visakorpi, T
Citation: N. Nupponen et T. Visakorpi, Molecular biology of progression of prostate cancer, EUR UROL, 35(5-6), 1999, pp. 351-354
Authors:
Pan, Y
Kytola, S
Farnebo, F
Wang, N
Lui, WO
Nupponen, N
Isola, J
Visakorpi, T
Bergerheim, USR
Larsson, C
Citation: Y. Pan et al., Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping, CYTOG C GEN, 87(3-4), 1999, pp. 225-232
Authors:
Nupponen, NN
Visakorpi, T
Citation: Nn. Nupponen et T. Visakorpi, Assignment of the protein kinase homolog of YAK1 (HIPK3) to human chromosome band 11p13 by in situ hybridization, CYTOG C GEN, 87(1-2), 1999, pp. 102-103